Lincoln Pharmaceuticals Board Meeting Date
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
Lincoln Pharmaceuticals Ltd will hold a board meeting on August 13, 2026. The board will consider and approve unaudited financial results for the quarter ended June 2026.
Lincoln Pharmaceuticals scheduled a May 28 board meeting to approve annual financial results and dividend recommendations. This advance notice signals upcoming performance and payout disclosures.